P. Chatpar
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Rheumatoid Arthritis Research and Therapies 4
-
- Blood Coagulation and Thrombosis Mechanisms 1
- Co-authors
- George D. Wilner (1 shared paper)A P Kaplan (1 shared paper)Emilio Martín-Mola (2 shared papers)Eva W. Hessey (1 shared paper)Karel Pavelká (2 shared papers)Blas Frangione (1 shared paper)Paul E. Emery (2 shared papers)Peter T. Nash (2 shared papers)
- Journals
- Journal of Clinical Investigation (1 paper)Clinical Immunology (1 paper)The Lancet (1 paper)PubMed (2 papers)Arthritis & Rheumatism (1 paper)
- Partner nations
- United StatesSpainCzechia
In The Last Decade
P. Chatpar
6 papers receiving 438 citations
P. Chatpar's Hit Papers
Peers
Comparison fields: 5 of 39
- Rheumatology 356
- Internal Medicine 11
- Hematology 20
- Oncology 24
- Immunology 20
Countries citing papers authored by P. Chatpar
This map shows the geographic impact of P. Chatpar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chatpar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chatpar more than expected).
Fields of papers citing papers by P. Chatpar
This network shows the impact of papers produced by P. Chatpar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chatpar. The network helps show where P. Chatpar may publish in the future.
Co-authors
The 15 scholars most cited alongside P. Chatpar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial Hit paper breakdown → | 2017 | 415 |
| 2 | Effects of extravascular clotting on fibrinopeptide A levels in blood. | 1978 | 19 |
| 3 | Preliminary efficacy results of rituximab retreatment in patients with active rheumatoid arthritis | 2005 | 9 |
| 4 | Prevalence of IgE rheumatoid factor (IgE RF) in mixed cryoglobulinemia and rheumatoid arthritis. | 1987 | 8 |
| 5 | 1979 | 6 | |
| 6 | 2006 | 1 |
About P. Chatpar
P. Chatpar is a scholar working on Rheumatology, Hematology, Immunology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 6 papers that have together received 458 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (4 papers), Blood properties and coagulation (1 paper), Immune Response and Inflammation (1 paper), Blood Coagulation and Thrombosis Mechanisms (1 paper), Biomarkers in Disease Mechanisms (1 paper) and Sepsis Diagnosis and Treatment (1 paper). The work is most often cited by research in Rheumatology (356 citations), Internal Medicine (11 citations), Hematology (20 citations), Oncology (24 citations) and Immunology (20 citations). P. Chatpar has collaborated with scholars based in United States, Spain and Czechia. Frequent co-authors include George D. Wilner, A P Kaplan, Emilio Martín-Mola, Eva W. Hessey, Karel Pavelká, Blas Frangione, Paul E. Emery, Peter T. Nash, R Fleischmann and Y Levo. Their work appears in journals such as Journal of Clinical Investigation, Clinical Immunology, The Lancet, PubMed and Arthritis & Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.